The FDA has approved the once-weekly injectable basal insulin drug insulin efsitora alfa-gobe (Onswik, Eli Lilly) for use as ...

Same integrin family, very different risk profiles: what natalizumab's boxed PML warning and vedolizumab's VARSITY win mean for choosing between them, per Dr Lana Zhovtis Ryerson.

The USPSTF has long been made up of specialists in primary care and researchers with expertise in evaluating medical evidence, rather than specialists in any one field.

As AI diagnostic tools move from research to routine use in eye care, we want to know where ophthalmologists stand — not just on whether AI works but also on trust, accountability, and what the ...

A rapidly evolving understanding of inheritable ILD, including telomere and surfactant gene variants, is reshaping how clinicians think about genetic testing.

Signs of Epstein-Barr virus reactivation emerge weeks to months before MS attacks, offering new clues to what may trigger relapse and pointing to potential biomarkers and treatment targets.

Reframing homelessness as a ‘cognitive impairment crisis’ is key to developing policies that more effectively address Canada’s homelessness crisis, a new commentary suggests.

Older adults face nutritional and hydration challenges that can impair their recovery and independence, making early screening and individualized support essential.

Do late dinners cause weight gain, and is honey really healthier than sugar? This roundup tests 10 widely repeated nutrition myths against the evidence.

While stroke rates among older adults have declined over the past 30 years, incidence among adults aged 20-54 has nearly doubled, a new study shows.

Not every psoriasis relapse reflects biologic failure; missed doses, access gaps, or the wrong diagnosis can all mimic treatment resistance and change the next step.

A systematic review and meta-analysis compares survival outcomes with whole-pelvic vs prostate-only radiotherapy in men with clinically node-negative high-risk localized prostate cancer.